Industry Growth Insights published a new data on “Biosimilar Testing and Development Services Market”. The research report is titled “Biosimilar Testing and Development Services Market research by Types (Effector Binding, ELISA, Kinetic Binding Assays, ADCC & CDC Cell-Based Assays), By Applications (PK assay, Tiered Immunogenicity testing, NAb assays), By Players/Companies Eurofins Scientific, SGS, Charles River Laboratories, Pharmaceutical Product Development, Exova, Source BioScience, Intertek Group, Medistri, Pace Analytical Services, Sigma-Aldrich”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Biosimilar Testing and Development Services Market Research Report
By Type
Effector Binding, ELISA, Kinetic Binding Assays, ADCC & CDC Cell-Based Assays
By Application
PK assay, Tiered Immunogenicity testing, NAb assays
By Companies
Eurofins Scientific, SGS, Charles River Laboratories, Pharmaceutical Product Development, Exova, Source BioScience, Intertek Group, Medistri, Pace Analytical Services, Sigma-Aldrich
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
139
Number of Tables & Figures
98
Customization Available
Yes, the report can be customized as per your need.
Global Biosimilar Testing and Development Services Market Report Segments:
The global Biosimilar Testing and Development Services market is segmented on the basis of:
Types
Effector Binding, ELISA, Kinetic Binding Assays, ADCC & CDC Cell-Based Assays
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
PK assay, Tiered Immunogenicity testing, NAb assays
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Eurofins Scientific
- SGS
- Charles River Laboratories
- Pharmaceutical Product Development
- Exova
- Source BioScience
- Intertek Group
- Medistri
- Pace Analytical Services
- Sigma-Aldrich
Highlights of The Biosimilar Testing and Development Services Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Effector Binding
- ELISA
- Kinetic Binding Assays
- ADCC & CDC Cell-Based Assays
- By Application:
- PK assay
- Tiered Immunogenicity testing
- NAb assays
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Biosimilar Testing and Development Services Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Biosimilar testing and development services are a type of medical technology that help to create or improve biosimilars. These services can help to ensure that the biosimilars are safe and effective, and they can also help to speed up the process of bringing them to market.
Some of the key players operating in the biosimilar testing and development services market are Eurofins Scientific, SGS, Charles River Laboratories, Pharmaceutical Product Development, Exova, Source BioScience, Intertek Group, Medistri, Pace Analytical Services, Sigma-Aldrich.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Biosimilar Testing and Development Services Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Biosimilar Testing and Development Services Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Biosimilar Testing and Development Services Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Biosimilar Testing and Development Services Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Biosimilar Testing and Development Services Market Size & Forecast, 2020-2028 4.5.1 Biosimilar Testing and Development Services Market Size and Y-o-Y Growth 4.5.2 Biosimilar Testing and Development Services Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Effector Binding
5.2.2 ELISA
5.2.3 Kinetic Binding Assays
5.2.4 ADCC & CDC Cell-Based Assays
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 PK assay
6.2.2 Tiered Immunogenicity testing
6.2.3 NAb assays
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Biosimilar Testing and Development Services Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Biosimilar Testing and Development Services Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Effector Binding
9.6.2 ELISA
9.6.3 Kinetic Binding Assays
9.6.4 ADCC & CDC Cell-Based Assays
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 PK assay
9.10.2 Tiered Immunogenicity testing
9.10.3 NAb assays
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Effector Binding
10.6.2 ELISA
10.6.3 Kinetic Binding Assays
10.6.4 ADCC & CDC Cell-Based Assays
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 PK assay
10.10.2 Tiered Immunogenicity testing
10.10.3 NAb assays
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Effector Binding
11.6.2 ELISA
11.6.3 Kinetic Binding Assays
11.6.4 ADCC & CDC Cell-Based Assays
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 PK assay
11.10.2 Tiered Immunogenicity testing
11.10.3 NAb assays
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Effector Binding
12.6.2 ELISA
12.6.3 Kinetic Binding Assays
12.6.4 ADCC & CDC Cell-Based Assays
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 PK assay
12.10.2 Tiered Immunogenicity testing
12.10.3 NAb assays
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Effector Binding
13.6.2 ELISA
13.6.3 Kinetic Binding Assays
13.6.4 ADCC & CDC Cell-Based Assays
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 PK assay
13.10.2 Tiered Immunogenicity testing
13.10.3 NAb assays
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Biosimilar Testing and Development Services Market: Competitive Dashboard
14.2 Global Biosimilar Testing and Development Services Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Eurofins Scientific
14.3.2 SGS
14.3.3 Charles River Laboratories
14.3.4 Pharmaceutical Product Development
14.3.5 Exova
14.3.6 Source BioScience
14.3.7 Intertek Group
14.3.8 Medistri
14.3.9 Pace Analytical Services
14.3.10 Sigma-Aldrich